[go: up one dir, main page]

MX2017014417A - Vacunas contra el dengue. - Google Patents

Vacunas contra el dengue.

Info

Publication number
MX2017014417A
MX2017014417A MX2017014417A MX2017014417A MX2017014417A MX 2017014417 A MX2017014417 A MX 2017014417A MX 2017014417 A MX2017014417 A MX 2017014417A MX 2017014417 A MX2017014417 A MX 2017014417A MX 2017014417 A MX2017014417 A MX 2017014417A
Authority
MX
Mexico
Prior art keywords
den
conserved
virus
dengue
serotypes
Prior art date
Application number
MX2017014417A
Other languages
English (en)
Other versions
MX390966B (es
Inventor
Blight Joshua
Reyes-Sandoval Arturo
Lopez-Camacho Cesar
Original Assignee
Univ Oxford Innovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Oxford Innovation Ltd filed Critical Univ Oxford Innovation Ltd
Publication of MX2017014417A publication Critical patent/MX2017014417A/es
Publication of MX390966B publication Critical patent/MX390966B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10023—Virus like particles [VLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La invención se refiere a una proteína que comprende una pluralidad de secuencias de péptido conservadas o variantes de las mismas, en donde al menos una de las secuencias conservadas se conserva a través de todos los cuatro serotipos del virus del dengue DEN-1, DEN-2, DEN- 3 y DEN-4, y en donde las secuencias conservadas comprenden al menos parte de una secuencia de una o más proteínas no-estructurales de los serotipos del virus del dengue. La invención además se refiere a péptidos asociados, composiciones, ácidos nucleicos, vectores virales, partículas similares al virus, uso, kits de vacunación principal y de refuerzo, agentes y métodos.
MX2017014417A 2015-05-12 2016-05-11 Vacunas contra el dengue MX390966B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1508099.7A GB201508099D0 (en) 2015-05-12 2015-05-12 Dengue vaccines
PCT/GB2016/051358 WO2016181147A1 (en) 2015-05-12 2016-05-11 Dengue vaccines

Publications (2)

Publication Number Publication Date
MX2017014417A true MX2017014417A (es) 2018-06-20
MX390966B MX390966B (es) 2025-03-21

Family

ID=53489497

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017014417A MX390966B (es) 2015-05-12 2016-05-11 Vacunas contra el dengue

Country Status (6)

Country Link
US (1) US10350285B2 (es)
EP (1) EP3294331A1 (es)
BR (1) BR112017024283A8 (es)
GB (1) GB201508099D0 (es)
MX (1) MX390966B (es)
WO (1) WO2016181147A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11806393B2 (en) * 2017-02-10 2023-11-07 La Jolla Institute For Allergy And Immunology Flavivirus peptide sequences, epitopes, and methods and uses thereof
AU2018365296B2 (en) 2017-11-09 2023-11-23 Institut Pasteur A Zika virus chimeric polyepitope comprising non-structural proteins and its use in an immunogenic composition
CN111565746A (zh) 2018-01-06 2020-08-21 埃默杰克斯疫苗控股有限公司 用于预防和治疗多种黄病毒的mhc i类相关肽
US20240316174A1 (en) * 2021-02-05 2024-09-26 Unm Rainforest Innovations Bacteriophage virus-like particle vaccines against flavivirus non-structural protein 1
TW202423456A (zh) * 2022-10-21 2024-06-16 法商賽拉福柯蒂斯公司 表現選自denv、zikv及yfv之群之黃病毒之非結構抗原、誘導宿主中保護性cd8+t細胞免疫的多核苷酸及慢病毒載體
WO2025032613A1 (en) * 2023-08-07 2025-02-13 National Centre For Biological Sciences - Tifr mRNA VACCINE AGAINST DENGUE, METHOD(S) AND KIT THEREOF

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102409063A (zh) * 2001-12-04 2012-04-11 巴法里安诺迪克有限公司 黄病毒ns1亚单位疫苗
WO2011163628A2 (en) * 2010-06-24 2011-12-29 La Jolla Institute For Allergy And Immunology Dengue virus (dv) polypeptide sequences, t cell epitopes and methods and uses thereof

Also Published As

Publication number Publication date
US10350285B2 (en) 2019-07-16
MX390966B (es) 2025-03-21
GB201508099D0 (en) 2015-06-24
BR112017024283A2 (pt) 2018-07-24
WO2016181147A1 (en) 2016-11-17
US20180193446A1 (en) 2018-07-12
EP3294331A1 (en) 2018-03-21
BR112017024283A8 (pt) 2022-12-27

Similar Documents

Publication Publication Date Title
MX2017014417A (es) Vacunas contra el dengue.
CL2023000264A1 (es) Nuevos vectores virales adeno-asociados dirigidos al hígado
CO2020004738A2 (es) Variantes de cápsides de virus adenoasociados y métodos de uso de estas
CL2024000409A1 (es) Ácidos nucleicos recombinantes que codifican una o más proteínas cosméticas para usos estéticos.
MX2019011599A (es) Moleculas quimericas y usos de las mismas.
MX388331B (es) Variantes de virus adenoasociado y métodos de uso de estas
CL2024001715A1 (es) Anticuerpo aislado que se une a la proteína e del virus del dengue; y uso.
MX340880B (es) Vacunas mejoradas y metodos para uso de las mismas.
MX2022003658A (es) Vacunas contra el virus de la hepatitis b (vhb) y metodos para tratar el vhb.
CL2018000740A1 (es) Vectores del factor viii del virus adeno-asociado, partículas víricas asociadas y formulaciones terapéuticas que los comprenden
CL2012000447A1 (es) Composición o vacuna que comprende un vector viral de un paramixovirus aviar 8 (apmv-8) recombinante; método para producir dicho vector; y uso para preparar medicamento útil para inducir una respuesta inmunológica.
WO2017066764A3 (en) Modification of n-terminal region of capsid proteins for enhanced properties of adeno-associated viruses
EA201891415A8 (ru) Антигены вируса иммунодефицита человека, векторы, композиции и способы их применения
MX383330B (es) Particula tipo virus de flavivirus.
BR112022016992A2 (pt) Vacina com base em poxvírus recombinante contra ví-rus sars-cov-2
MX387396B (es) Un poliepitope quimerico de virus de dengue compuesto por fragmentos de proteinas no estructurales y su uso en una composicion inmunogenica contra infeccion de virus de dengue.
MX380455B (es) Vacunas de partículas tipo virus (vlp) contra el parvovirus canino (cpv) y sus usos.
MX2020001655A (es) Vacuna vph.
ES2387141T8 (es) Composición que comprende la poliproteína NS3/NS4 y el polipéptido NS5b del VHC, vectores de expresión que incluyen las secuencias nucleicas correspondientes y su utilización terapéutica
MX2020004833A (es) Un poliepitopo quimerico del virus del zika que comprende proteinas no estructurales y su uso en una composicion inmunogenica.
CO6541529A2 (es) Método, plasmideo y composición para inducir una respuesta inmune contra virus de la dengue basado en vacunas de adn y virus quimericos
AR108014A1 (es) Vacuna universal para enfermedades virales y método de vacunación
AR095425A1 (es) Vacuna, uso y procedimiento para prevenir una infección por picornavirus
PH12018502197A1 (en) Improved method for producing virus like particles
MX2018000023A (es) Particulas semejantes a virus recombinantes que utilizan la proteina gag del virus de inmunodeficiencia bovina.